Clinical Trials at University of Illinois at Chicago
As of September 2026, 60 paid clinical trials are recruiting at University of Illinois at Chicago, located at 912 S WOOD ST, CHICAGO, IL 60612-4300, phone (312) 996-5754 in Chicago, Illinois. Active studies at this site cover conditions such as Breast Cancer, Obesity and Stroke. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Chicago
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Antibiotics After Incision and Drainage to Prevent Fistula Formation After First Episode of Perianal Abscess
62 clinical trials at University of Illinois at Chicago
·Clear filters·A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
ELEVATE High-Risk PCI Pivotal Study
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer
The SENTINL-1 Study: Evaluating Patient-Reported Outcomes of AI-Inferred Lung Cancer Risk
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Post-Autologous Transplant Maintenance With Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma
Home Based Functional Balance Intervention for Multiple Sclerosis
Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
Role of Adiposomes in Endothelial Dysfunction
Aging and Task-specific Training to Reduce Falls
Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease
Alternative Therapies for Improving Physical Function in Individuals With Stroke
Dual Task Perturbation Training for OAwMCI
Analysis of Human ALS Tissues and Registry of ALS Patients
Home-based FES Training in People With Chronic Stroke
The REACTplusNMES Trial: A Double-blinded RCT
Functional Balance Intervention in Multiple Sclerosis
Reactive Balance Training for Fall Prevention
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Better Lifestyle Counseling for African American Women During Pregnancy
STM-06: POLARIS-POlymetastic Lesion Ablative Radiotherapy With Immunotherapy Study
Longitudinal Study of the Porphyrias
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
Effect of NMES on Balance and Fall Risk in Chronic Stroke
Probiotic Supplementation in Optimizing Iron and Hematological Status Among Pregnant Females
StuDy AimED at Increasing AlCohol AbsTinEnce
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Common conditions studied in Chicago
- Breast Cancer (35 active studies)
- Obesity (26 active studies)
- Stroke (25 active studies)
- Heart Failure (24 active studies)
- Acute Myeloid Leukemia (23 active studies)
- Hypertension (22 active studies)
Leading research sponsors in Chicago
- Northwestern University
- University of Chicago
- University of Illinois at Chicago
- National Cancer Institute (NCI)
- Rush University Medical Center
Frequently asked questions
How many paid clinical trials are currently recruiting in Chicago?
There are approximately 2,142 recruiting clinical trials in Chicago, Illinois listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Chicago pay participants?
Most recruiting trials in Chicago compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Chicago?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Chicago?
The most common conditions under active study in Chicago include Breast Cancer (35), Obesity (26), Stroke (25), Heart Failure (24), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Chicago?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Chicago on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Chicago?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Chicago?
Recruiting research sites in Chicago include Northwestern University, University of Chicago, Rush University Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Chicago right now?
The largest active categories in Chicago are Cancer & tumors (597), Neurology & pain (148), Cardiovascular (116). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of University of Illinois at Chicago?
University of Illinois at Chicago is located at 912 S WOOD ST, CHICAGO, IL 60612-4300. Use the Google Maps link in the intro above to get directions.
How do I contact University of Illinois at Chicago?
You can reach University of Illinois at Chicago by phone at (312) 996-5754. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.